AgingResearch.News
CellsPeer-reviewed

Extracellular vesicles carrying two microRNAs reduce vascular aging markers in progeria cells

Vesicles from melatonin-treated stem cells targeted SRSF1 and SP1 to lower progerin and cellular prion protein in cell models.

Pharmacological research · Joo EY et al. · Paper published 29 Sep 2026

Paper

In experiments using human cellular models and serum from an index patient with Hutchinson-Gilford progeria syndrome, researchers tested small extracellular vesicles from melatonin-preconditioned mesenchymal stromal cells. The patient's serum showed elevated progerin, cellular prion protein, and troponin I levels, and it impaired endothelial tube formation. Treating endothelial cells and progeria fibroblasts with these vesicles reduced endothelial dysfunction, progerin, cellular prion protein, p16, and DNA damage markers. Mechanistically, vesicle-derived miR-4651 targeted SRSF1 to lessen nuclear-lamina defects, while miR-6126 targeted SP1 to decrease cellular prion protein expression. A virtual-cohort analysis prioritized combining lonafarnib with these vesicles or microRNAs.

Why it matters

The study links cellular prion protein to progeria-associated vascular disease alongside classical progerin toxicity. It highlights dual-microRNA delivery as a potential strategy to target multiple vascular injury and cellular senescence pathways simultaneously.

Caveats

The findings are limited to cell-culture models and serum from a single index patient. Additionally, the therapeutic combinations were prioritized using a computational virtual-cohort analysis without a consistently top-ranked regimen across models.

Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.

The paper

MT-Exo-derived miR-4651 and miR-6126 coordinately regulate the SRSF1-progerin and SP1-PrPᶜ axes to attenuate vascular aging in HGPS

Joo EY, Yoon U, Lee J et al.

Pharmacological research · 29 Sep 2026 · Peer-reviewed

Relevance
Core geroscience
News value
Notable
Evidence
Cells
Status
Peer-reviewed